Formosa Laboratories, Inc. (TPE:4746)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
53.80
+1.30 (2.48%)
Mar 5, 2026, 1:30 PM CST

Revenue by Segment

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
Other Operating Departments
153.36M31.17M1.32M28.53M-
Other Operating Departments Growth
391.99%2270.49%-95.39%--
Active Pharmaceutical Ingredients(API)
4.61B4.35B3.80B3.17B3.11B
Active Pharmaceutical Ingredients(API) Growth
5.96%14.25%20.04%1.96%11.49%
Write-Off Due to Consolidation
-27.50M-17.02M-39.96M-55.15M-32.63M
Total
4.73B4.36B3.77B3.14B3.08B
Total Growth
8.50%15.80%19.83%2.18%11.45%

Revenue by Geography

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15
United States
631.35M269.32M190.34M116.20M222.77M
United States Growth
134.43%41.49%63.80%-47.84%168.23%
India
1.06B1.03B918.78M751.38M631.40M
India Growth
2.50%12.23%22.28%19.00%-3.06%
Netherlands
588.64M577.20M377.80M88.44M361.46M
Netherlands Growth
1.98%52.78%327.18%-75.53%-11.46%
China
217.95M272.57M220.02M137.11M-
China Growth
-20.04%23.88%60.47%--
Taiwan
338.18M278.08M380.51M306.38M234.70M
Taiwan Growth
21.61%-26.92%24.19%30.54%-9.60%
Germany
250.63M306.89M231.16M247.22M165.23M
Germany Growth
-18.33%32.76%-6.50%49.62%33.06%
Japan
262.69M311.98M228.75M253.81M253.24M
Japan Growth
-15.80%36.38%-9.87%0.23%27.54%
Other
1.19B1.04B729.28M349.07M526.89M
Other Growth
14.06%42.78%108.92%-33.75%-2.38%
Switzerland
197.06M272.05M280.35M333.46M231.73M
Switzerland Growth
-27.57%-2.96%-15.93%43.90%23.72%
Spain
---290.04M82.90M
Spain Growth
---249.88%147.50%
Canada
--208.52M269.29M365.15M
Canada Growth
---22.57%-26.25%33.22%
Total
4.73B4.36B3.77B3.14B3.08B
Total Growth
8.50%15.80%19.83%2.18%11.45%
Source: S&P Global Market Intelligence.